Acurx Pharmaceuticals to add up to $1 million in bitcoin for treasury reserve, following MicroStrategy's playbook

The company's shares dropped over 6% after surging 8% in premarket trading. The CEO believes in bitcoin's potential as a treasury asset, following MicroStrategy's lead. Corporate bitcoin adoption is growing slowly but steadily, with potential regulatory support in the future.